Hepion (HEPA) grants interim CEO 1.35M options at $0.08
Rhea-AI Filing Summary
Hepion Pharmaceuticals, Inc. (HEPA) reported that Interim CEO and director Gary S. Stetz received a grant of stock options for 1,345,500 shares of common stock. The options have an exercise price of $0.08 per share and expire on August 19, 2036. According to the grant terms, 336,375 options vest immediately, and the remaining options vest in equal monthly installments over six months from the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Stetz Gary S.
Role
Interim CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options F1 | 1,345,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options — 1,345,500 shares (Direct)
Footnotes (1)
- F1. 336,375 options vest upon grant and the remaining amount vests in equal amounts monthly over 6 months from date of grant.
Key Figures
Stock options granted: 1,345,500 options
Exercise price: $0.08 per share
Options vesting upon grant: 336,375 options
+3 more
6 metrics
Stock options granted
1,345,500 options
Grant of stock options to Interim CEO Gary S. Stetz on 2026-08-19
Exercise price
$0.08 per share
Conversion or exercise price of granted stock options
Options vesting upon grant
336,375 options
Portion of options that vest immediately on grant date
Remaining options vesting period
6 months
Remaining options vest in equal monthly amounts over six months from grant
Expiration date
August 19, 2036
Expiration of granted stock options
Options held after transaction
1,345,500 options
Total derivative securities following the grant
Key Terms
Stock Options, exercise price, vesting, expiration date
4 terms
Stock Options financial
"security_title: "Stock Options""
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
exercise price financial
"conversion_or_exercise_price: "0.0800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"336,375 options vest upon grant and the remaining amount vests"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: "2036-08-19""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transaction did HEPA report for Gary S. Stetz?
Hepion Pharmaceuticals (HEPA) reported that Interim CEO Gary S. Stetz received a grant of 1,345,500 stock options to purchase common stock at an exercise price of $0.08 per share, expiring on August 19, 2036.
What is the vesting schedule of the new HEPA stock options granted to Gary S. Stetz?
Of the 1,345,500 Hepion (HEPA) stock options granted to Gary S. Stetz, 336,375 vest upon grant, and the remaining options vest in equal amounts monthly over six months from the date of grant.
What is the exercise price of Gary S. Stetz’s new HEPA stock options?
The exercise price of Gary S. Stetz’s new Hepion (HEPA) stock options is $0.08 per share for 1,345,500 underlying shares of common stock.
When do the newly granted HEPA stock options to Gary S. Stetz expire?
The stock options granted to Gary S. Stetz by Hepion (HEPA) expire on August 19, 2036, giving him the right to purchase shares at $0.08 per share until that date, subject to vesting.
How many HEPA derivative securities does Gary S. Stetz hold after this option grant?
Following this transaction, Gary S. Stetz holds 1,345,500 stock options related to Hepion (HEPA) common stock as reported in this filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
